Startups are curious beasts. They move fast, break things, raise millions, and yet remain spectacularly unable to define who is

Introduction: Platforms, Promise, and the VC Paradox Biotechnology has always been a high-stakes endeavor, with the odds stacked against any

If you’ve been through business school, corporate training, or an executive retreat, chances are you’ve encountered the holy

Strategy was once a noun. Then someone turned it into a 2x2 matrix and started charging €400/hour for it.

Foundations of a Gene Therapy Pioneer (1992–2010) bluebird bio began not as the vibrant name suggests, but as a

In the spirit of Thatcher—and with apologies to everyone who just spat out their ethically sourced oat milk—here’

The biotechnology sector continuously faces significant funding challenges, balancing the enormous costs of clinical development with the necessity of minimizing

If there’s one thing that consistently frustrates me, it’s how pseudoscientific claims are dressed up as life-saving innovations.

Conflicting Narratives in a Growing Sector China’s early-stage biotech and drug development startups have been riding a seesaw of

Biotech IPOs: A Tale of Two Continents Not long ago, biotech firms queued eagerly for public markets, buoyed by cheap